ASCO GU

Clinical data, expert insights, and treatment advancements presented at the ASCO Genitourinary Cancers Symposium, focusing on practice-informing updates across GU malignancies.

Bladder Cancer

View All

HER2-Directed Strategies in Urothelial Cancer, featuring Dr. Miles Hsu and Dr. Brendan Guercio discussing innovative treatments for bladder cancer, with a cityscape background.

Bladder Cancer

03/15/2026

Novel HER2–Targeting Therapies in Urothelial Cancer

Miles Hsu, MDBrendan Guercio, MD

Researchers Brendan Guercio, MD, and Andrea Apolo, MD, discuss circulating tumor DNA for guiding muscle-invasive bladder cancer treatment, with a cityscape background.

Bladder Cancer

03/13/2026

Circulating Tumor DNA to Guide Treatment in Muscle-Invasive Bladder Cancer

Brendan Guercio, MDAndrea Apolo, MD

EV Plus Pembro improves outcomes in muscle-invasive bladder cancer in KEYNOTE-B15/EV-304, featuring researchers Rohit Gosain, MD, and Rahul Gosain, MD, MBA, with a cityscape background.

Bladder Cancer

03/10/2026

Enfortumab Vedotin Plus Pembrolizumab Improves Outcomes in Muscle-Invasive Bladder Cancer in KEYNOTE-B15/EV-304

Rahul Gosain, MD, MBARohit Gosain, MD

Efficacy of Enfortumab Vedotin and Pembrolizumab in muscle-invasive bladder cancer treatment, featuring experts Elias Chandran and Vishesh Khanna against a cityscape background.

Bladder Cancer

03/09/2026

Enfortumab Vedotin-Pembrolizumab’s Role in Muscle-Invasive Bladder Cancer Treatment

Elias Chandran, MBBS, FRACPVishesh Khanna, MD

Evolving treatment strategies in bladder cancer research presented by OncUpdates, featuring medical professionals discussing innovative therapies and recent advancements in bladder cancer management.

Bladder Cancer

03/09/2026

Insights from ASCO GU 2026: Evolving Treatment Strategies in Bladder Cancer

Zeynep Irem Ozay, MD

Enhanced immunotherapy plus BCG treatment for high-risk non-muscle invasive bladder cancer; two doctors in formal attire with cityscape background.

Bladder Cancer

03/08/2026

Immunotherapy Plus BCG Shows Promise in NMIBC: Insights From POTOMAC and CREST

Ashish M. Kamat, MD, MBBS, FACSVishesh Khanna, MD

General GU Oncology

View All

Advanced medical professionals discussing bladder, kidney, and prostate cancer updates at ASCO GU 2026 conference.

General GU Oncology

03/25/2026

Bladder, Kidney, and Prostate Cancer Highlights From ASCO GU 2026

Petros Grivas, MD, PhDRahul Gosain, MD, MBARohit Gosain, MD

Bladder, prostate, and kidney cancer updates from ASCO GU 2026, featuring medical professionals discussing recent advancements in cancer treatment and research.

General GU Oncology

03/20/2026

ASCO GU 2026: Key Updates in Bladder, Prostate, and Kidney Cancer

Charbel Matar, MD

Prostate Cancer

View All

EV Plus Pembrolizumab and Systemic Therapy Advances in GU Oncology - OncUpdates.

Prostate Cancer

03/16/2026

Community Takeaways From ASCO GU 2026

Regina Barragan-Carrillo, MDRaji Shameem, MD

Advanced molecular testing and targeted therapies for prostate cancer research and treatment.

Prostate Cancer

03/16/2026

ASCO GU 2026: Experts Highlight Key Updates in Prostate Cancer

Brooke Kania, DOSindhuja Kadambi, MD, MS

Postoperative radiation and personalized therapy in GU cancers, featuring two smiling female doctors against a cityscape background.

Prostate Cancer

03/16/2026

A Personalized Approach to Treating GU Cancers

Sophia Kamran, MDNatalie Reizine, MD

Advanced medical professionals discussing Radium-223 Plus Enzalutamide in mCRPC with bone metastases in an urban hospital setting.

Prostate Cancer

03/14/2026

PEACE-3 OS Data Support Radium-223 Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Sindhuja Kadambi, MD, MSKarine Tawagi, MD

PARP inhibitor combination therapy in metastatic prostate cancer, featuring Jeffrey Zhong, MD, and Karan Jatwani, MD, with a cityscape background.

Prostate Cancer

03/11/2026

PARP Inhibitor Combination Therapy in Metastatic Prostate Cancer

Karan Jatwani, MDJeffrey Zhong, MD

Advanced prostate cancer treatment research featuring Karan Jatwani, MD, and Alan Bryce, MD, with a city skyline background.

Prostate Cancer

03/06/2026

Capivasertib Plus Abiraterone in Metastatic Prostate Cancer

Alan Bryce, MDKaran Jatwani, MD

RCC

View All

Advanced renal cell carcinoma research on HIF-2α inhibition featuring Dr. Michael Serzan and Dr. Toni Choueiri, with a cityscape background, highlighting innovative cancer treatment developments.

RCC

03/16/2026

Positive Trials for Belzutifan in Earlier Treatment Lines for RCC

Michael Serzan, MDToni Choueiri, MD

Radiotherapy strategies in metastatic clear cell renal cell carcinoma featuring Dr. Shreyas Kalantri and Dr. Michael Serzan with a cityscape background.

RCC

03/15/2026

Radiotherapy Strategies in Metastatic Clear Cell Renal Cell Carcinoma

Michael Serzan, MDShreyas Kalantri, MD

Enhanced cancer treatment research featuring Dr. Nicholas Simon and Dr. Sumanta Pal discussing Cabozantinib and novel doublets in advanced renal cell carcinoma.

RCC

03/12/2026

Cabozantinib and Novel Doublets in Advanced RCC

Nicholas Simon, MDSumanta Pal, MD, FASCO

Advanced medical professionals discussing metastatic renal cell carcinoma treatment strategies in a modern urban setting.

RCC

03/12/2026

First-Line Treatment Strategies in Metastatic Renal Cell Carcinoma

Andre Kydd, MD, PhDNicholas Simon, MD

Evolving standards in renal cell carcinoma research and treatment, with practical insights for healthcare professionals and oncologists.

RCC

03/05/2026

Evolving Standards in Renal Cell Carcinoma: Practical Insights from ASCO GU

Adriana Penate, MD